|
HS Code |
366200 |
| Productname | 2,6-Dibromo-4-Methoxypyridine |
| Casnumber | 511296-38-1 |
| Molecularformula | C6H5Br2NO |
| Molecularweight | 282.92 g/mol |
| Appearance | Off-white to pale yellow solid |
| Meltingpoint | 81-85°C |
| Solubility | Soluble in organic solvents such as DMSO and ethanol |
| Purity | Typically ≥98% |
| Smiles | COC1=CC(Br)=NC(Br)=C1 |
| Inchi | InChI=1S/C6H5Br2NO/c1-10-5-2-4(7)9-6(8)3-5/h2-3H,1H3 |
As an accredited 2,6-Dibromo-4-Methoxypyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 2,6-Dibromo-4-Methoxypyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of fine chemicals, some compounds play a behind-the-scenes role that shapes pharmaceutical progress and synthetic research. My own experience in research labs and sourcing for specialized projects has taught me that the right building block can make or break a synthesis route. Take 2,6-Dibromo-4-Methoxypyridine as a case in point. This molecule often flies under the radar, yet it opens doors for those working in organic chemistry because of its unique substitution pattern and reactivity. Every time I’ve encountered it in the literature or a lab order, someone was pushing the boundaries of their field—not just following a template.
The structure of 2,6-Dibromo-4-Methoxypyridine places two bromine atoms at the 2 and 6 positions of the pyridine ring, while the methoxy group resides at position 4. At a glance, that seems simple, but anyone who’s ever sat down with a reaction scheme knows this arrangement gives the compound selective reactivity. Experienced chemists will notice how the presence of bromine atoms at those locations blocks unwanted side reactions, making the molecule much more predictable in cross-coupling strategies. A methoxy group, though not as flashy in name, changes the electronic environment, increasing the usefulness of the pyridine core in designing more complex molecules.
When developing pharmaceutical leads or agricultural agents, a researcher needs intermediates that do their job cleanly, without dragging along a sackful of side reactions. I’ve seen 2,6-Dibromo-4-Methoxypyridine included in routes that demand site-selectivity or need a reliable starting block for arylation reactions. Some projects in which my colleagues have been involved demanded a compound like this to introduce pyridine functionality while keeping modifications open for multiple paths down the road. Suzuki and Buchwald–Hartwig couplings, for example, call for robust partners, and the bromine atoms here turn this pyridine into a ready candidate. For those tracking yields, reductions in by-products spell less time cleaning up and more focus on crafting the molecules that matter.
Nobody enjoys ordering a material, storing it, and discovering it has lost potency months later. I’ve worked with enough air-sensitive or light-sensitive reagents to know the headache they cause. 2,6-Dibromo-4-Methoxypyridine comes as a stable crystalline solid. Everyday precautions in a dry container and a dark spot on the shelf typically suffice. You won’t find yourself constantly worrying about decomposition under normal laboratory conditions. This reliability means the compound doesn’t slow research teams down—an underrated benefit when deadlines loom and every batch counts.
For anyone who has spent hours comparing catalogues and technical data, it becomes clear that small changes in substitution on the pyridine ring lead to substantially different properties. Try using a monosubstituted pyridine when a disubstituted version is called for, and you’ll hit obstacles in selectivity. Some colleagues opted for 2,6-dichloropyridine or 2-bromo-6-methylpyridine in the past. The problem was either reactivity mismatches or complications during purification. The dibromo-methoxy combination of this molecule makes it stand out among shuffled alternatives. Its unique arrangement gives it a distinct niche—more reactive than dichloro derivatives, and cleaner in downstream handling compared to many others. Swap out one group for another, and you move from a straightforward process to troubleshooting unexplained by-products.
Research requires reliability and accessibility. Teams working on medicinal chemistry projects tend to gravitate toward building blocks that streamline optimization cycles. Data from recent patent applications and synthetic journals confirms the growing interest in halogenated and methoxy-substituted pyridines. Reported syntheses involving this compound have demonstrated improved regioselectivity and higher throughput in late-stage functionalizations compared to more basic pyridines. In my time assisting with small-molecule synthesis projects, the ability to reduce the number of steps and purifications brought significant cost and time savings. That kind of impact echoes across the entire pipeline—less wasted effort and more opportunities to push leads forward.
Working responsibly with brominated materials is part of modern laboratory life. The trend has moved toward greener practices, mindful of the environmental load but unwilling to sacrifice efficiency. Despite its halogen content, 2,6-Dibromo-4-Methoxypyridine does not introduce unexpected hazards compared to common laboratory chemicals. Waste mitigation plans, such as those employed in the pharmaceutical sector, show brominated intermediates can be managed effectively with appropriate neutralization and capture processes. From my own perspective, handling this material falls well within the comfort zone of a research chemist used to working with pyridines and related heterocycles.
Over years spent reviewing successful case studies in medicinal chemistry, the choice of building blocks often sets the stage for novel compounds reaching preclinical studies. The added bromine atoms, paired with a methoxy group, increase the range of substitution reactions available on the pyridine core. Researchers aiming to modify scaffolds for biological testing need access to reliable substitution points, and this particular molecule delivers on that front. Reports from major pharmaceutical synthesis teams highlight that routes using this intermediate often trim down total steps and raise final yields. The difference between success and a dead end sometimes comes down to picking the right intermediate at the outset—bypassing countless cycles of trial and error.
A chemical’s value comes not from rarity but from how well it fits the problems synthetic chemists face. For those developing kinase inhibitors, antibacterial scaffolds, or even complex agrochemicals, having two bromine atoms sitting in key spots spells versatility. The extra electron density from the methoxy group not only helps in further transformations, it often leads to better stability and handling during multi-step sequences. People who have worked with less forgiving analogues know the cost of repetitive purification and losses due to instability. That kind of practical detail matters to anyone thinking beyond the reaction vial to scale-up and reproducibility.
I’ve talked with bench chemists and project leads who brought up this specific pyridine when discussing bottlenecks in innovative synthetic sequences. Their experiences mirror my own. After switching to a dibromo-methoxy-pyridine from less reactive halogenated analogues, they reported fewer sidesteps. They could push for faster cycles, and rarely needed to troubleshoot unexpected side products. It’s this ease of integration that keeps the compound in circulation, especially for time-sensitive deliverables. Even outside big pharma—at universities and CROs—I’ve seen procurement specialists keeping it on hand, knowing it reliably supports demanding projects.
The reach of 2,6-Dibromo-4-Methoxypyridine stretches beyond basic synthesis. In the field of materials science, researchers lean on such heterocycles to introduce electronic modifications to ligands and polymers. The compound’s structural traits lend themselves to exploratory work in organic electronics and sensor development. While synthetic drug design dominates the conversation, I’ve observed presentations at technical conferences that put this molecule forward as a keystone for assembling functionalized surfaces. Its reactivity under controlled conditions makes it a tool for both advanced research and emerging applications.
Supply chain integrity stands out as a reality check on any advanced project. Authenticity concerns run high in research circles, especially for molecules that underpin entire routes. During the course of audit and development work, researchers and purchase managers alike have raised concerns over batch purity and sourcing transparency. 2,6-Dibromo-4-Methoxypyridine, due to its relatively focused demand, often comes from reputable suppliers who commit to analytical verification. High performance liquid chromatography and NMR reports typically accompany shipped material, offering assurance that the lot will perform as expected. Keeping tabs on the credentials of suppliers and insisting on transparent data remains a must, and in my experience, sticking to vetted sources guards against nasty surprises.
For those interested in the nuts and bolts, understanding the technical details of any chemical means more successful experiments. 2,6-Dibromo-4-Methoxypyridine weighs in with a molecular formula of C6H5Br2NO. Its white to off-white solid appearance signals its solid state at room temperature, a benefit for weighing and measuring without solvent hassle. Melting point ranges tend to cluster in reproducible intervals, which helps spot adulterated or degraded material. Solubility in organic solvents such as dichloromethane and ethyl acetate allows for smooth phase transfers and easy workups, something any lab veteran will immediately appreciate.
Any chemical, no matter how useful, comes with constraints. For some cost-conscious research departments, the price tag on advanced halogenated pyridines limits routine use. My own efforts to budget synthetic runs often involved careful rationing of specialty intermediates, prioritizing compounds like this one for critical steps. Some workflows benefit more than others from the features of dibromo-substituted heterocycles, so decision-makers weigh the trade-off between raw material expense and project payoff. Regional restrictions on brominated intermediates also exist, pushing some groups to seek out local suppliers or adjust protocols to align with stricter import controls. Being aware of these potential speedbumps can help teams plan purchasing and regulatory navigation up front.
Plenty of companies and research groups scrutinize every intermediate through the lens of available alternatives. Few replacements can match the selectivity and straightforward reactivity offered here without introducing extra complications elsewhere. Generic bromopyridines or mono-substituted analogues bring their own set of headaches: lower coupling rates, greater by-product risks, or less robust downstream handling. By comparison, this molecule avoids many of those pitfalls, acting as a shortcut rather than a detour in reaction design. Choosing alternatives often means trading off time, labor, and reliability, lessons only learned after frustrating cycles of optimization.
With research attention shifting toward complex, polyfunctional molecules, the demand for specialist building blocks like 2,6-Dibromo-4-Methoxypyridine is likely to grow. Rising standards in medicinal chemistry and molecular design keep pushing expectations higher. I’ve seen calls for more sophisticated starting blocks in grant applications and new method publications every month. Teams want intermediates that lend themselves to modular assembly, minimize waste, and support late-stage diversification. This molecule checks those boxes, ensuring continued interest from both innovators and established players. As attention turns toward greener processes, the hope is that more sustainable production and disposal routes will keep pace.
Journals like Organic Letters, Journal of Medicinal Chemistry, and Advanced Synthesis & Catalysis regularly feature work built around such substituted pyridines. Data-driven reviews highlight the molecule’s role in improving yields for Suzuki-Miyaura and palladium-catalyzed amination reactions. Some recent articles also chart the impact of the methoxy group in modifying physicochemical profiles for bioactive molecules. Keeping up with published case studies gives project teams a chance to benchmark their own results, fine-tune conditions, and avoid pitfalls already mapped out by others.
In my own mentoring of new researchers, I steer them toward understanding the subtle value in intermediates like 2,6-Dibromo-4-Methoxypyridine. Textbook training rarely covers the headaches that come with mismatched reactivity and endless troubleshooting. The right starting material, as they quickly learn in the lab, can spell the difference between a week-long struggle and a smooth set of results. Awareness of the tools available and smart choice of entry points for synthesis allow newcomers to focus their energy on scientific questions, not cleanup chores.
Every field advances by gathering the best tools and knowing when to use them. 2,6-Dibromo-4-Methoxypyridine has earned a dedicated following by making complex chemistry a little bit easier. In reviewing my own projects and the stories shared at conferences, recurring themes appear: dependability in selective couplings, smoother purification, and compatibility with modern functionalization methods. The hands-on experience of staff in process chemistry, who must scale up reactions and deliver reproducible results, adds weight to its track record.
Looking forward, labs will keep searching for intermediates that strike the right balance between reactivity, availability, and responsible stewardship. Regulations may evolve alongside progress in green chemistry, pushing demand for cleaner processes alongside robust compounds. Those invested in shaping the next wave of advances—whether in healthcare, crop science, or materials—have every reason to look at 2,6-Dibromo-4-Methoxypyridine as more than a line in a catalog. It represents the thought, experience, and collaboration at work every time chemists bring new ideas to life. With the right approach to sourcing, safety, and continuing education, this molecule stands ready to power progress for years to come.